SpinChem and ChemiSky have entered a partnership. Third from the right in the picture, Jeff Lee, CEO of ChemiSky, next to SpinChem's Tove Näsman, Business Manager, and Emil Byström, CEO. SpinChem has entered a new partnership with South Korea-based ChemiSky to accelerate the transition from lab results to decision‑grade pilots in industrial liquid-phase synthesis, purification and bioprocessing.
The partnership will help industrial teams move faster from development to scale by improving throughput, product quality, and process reliability, while reducing waste and energy use. The collaboration is enabled by SpinChem’s rotating bed reactor (RBR) technology and supported by ChemiSky’s strong local presence in process engineering and pilot systems.
South Korea is a fast-growing, performance-driven market for industrial processing, with its pharmaceutical sector projected to reach USD 54 billion by 2032. Together, SpinChem and ChemiSky will focus on applications where performance can be validated quickly through measurable proof-of-concept studies and pilot projects, and where operational reliability delivers immediate value.
Key focus areas include:
SpinChem's RBR technology provides an advantage
“Industrial teams are under pressure to increase throughput and deliver consistent quality while reducing complexity and waste. South Korea is a fast-moving market, and ChemiSky strengthens our ability to support customers locally at that pace,” said Dr. Emil Byström, CEO of SpinChem.
“South Korea’s pharma and bioprocess sectors are scaling rapidly. The winners will be the teams that can move reliably from lab results to decision-grade proof. SpinChem’s RBR technology provides that advantage,” said Jeff Lee, CEO of ChemiSky.
About SpinChem
* SpinChem’s vision is to accelerate the transformation of the global process industry through simple, fast, and sustainable technical solutions.
* Based in Umeå, Sweden, SpinChem develops rotating bed reactor (RBR) systems for synthesis, manufacturing, and purification, from lab to production scale.
About ChemiSky
ChemiSky Co., Ltd. is a process engineering company based in Anyang-si, South Korea. Established in 1989, ChemiSky supplies scientific test equipment and pilot systems.
For more information
Dr. Emil Byström, CEO, SpinChem AB
Email: info@spinchem.com
Phone: +46 70-689 2501
Web: spinchem.com
Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.
Powered by Notified